Georgina Morley, PhD
- Call 216.444.8720
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Georgina Morley, PhD
Georgina Morley, PhD is Director of the Nursing Ethics Program (NursE Program), an innovative collaborative program between the Center for Bioethics and the Nursing Institute. The NursE Program is dedicated to nurturing and sustaining a network of nurses to develop expertise in examining the ethical dimensions of patient care through the lens of nursing practice. The program is focused on five core areas: nurse education, scholarly work, clinical excellence, program development and the development of interventions to address moral distress.
Dr. Morley was appointed as Assistant Staff, Nurse Ethicist in June 2020 within the Center for Bioethics and works closely with the Nursing Institute and the Heart, Vascular and Thoracic Institute (HVTI). Georgina received a BA in Philosophy from King’s College London and went on to train as a nurse, receiving a Post Graduate Diploma in Adult Nursing in 2012 and a Masters of Science in Nursing from King’s College London in 2014. Dr. Morley is a registered nurse in the United Kingdom, having worked on the Major Trauma Ward at St. Mary’s Hospital, Imperial College Healthcare NHS Trust and in Cardiac Critical Care at Barts Heart Centre, Barts Health NHS Trust.
Dr. Morley went on to complete her doctoral studies at the University of Bristol, Centre for Ethics in Medicine exploring moral distress as experienced by critical care nurses in the United Kingdom. Georgina’s PhD was a feminist empirical bioethics project entitled, “What is ‘moral distress’ in nursing and how should we respond to it?” and was funded by a prestigious Wellcome Trust Society and Ethics Fellowship for Healthcare Professionals. Georgina is recognized as an international expert on moral distress, has been invited to speak on the topic in both the UK and US, and has published peer-reviewed papers and book chapters on the topic.
Dr. Morley has expertise in qualitative research methods (in particular phenomenology), empirical bioethics, moral distress, nursing ethics and clinical ethics.
Education & Professional Highlights
Appointed
2020
Education & Fellowships
Graduate School - University of Bristol
Bristol,
UK
2018
Internship - University of Birmingham
Doctoral Studentship; Enrollment only, transferred to University of Bristol
Birmingham, England,
2017
Graduate School - King's College London
London,
UK
2014
Graduate School - King's College London
PostGraduate Diploma in Adult Nursing
London,
UK
2012
Undergraduate - King's College London
Philosophy
UK
2010
Professional Highlights
Education & Fellowships
Nursing Ethics Fellowship – Cleveland Clinic
Graduate School – University of Bristol
PhD BioethicsNursing – King’s College London
MSc Nursing,
PG Dip, Adult Nursing with RegistrationUndergraduate – King’s College London
BA Philosophy
Research & Publications
See publications for Georgina Morley, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/31/2024, Dr. Morley has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
